cqp 201-403 has been researched along with Pituitary Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, EF; Brownell, J; Burrin, JM; Venetikou, MS; Woods, CA; Yeo, TH | 1 |
1 other study(ies) available for cqp 201-403 and Pituitary Neoplasms
| Article | Year |
|---|---|
Effects of two novel dopaminergic drugs, CV 205-502 and CQP 201-403, on prolactin and growth hormone secretion by human pituitary tumours in vitro.
Topics: Aminoquinolines; Animals; Ergolines; Growth Hormone; Humans; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Receptors, Dopamine; Tumor Cells, Cultured | 1987 |